Guiming M. Hu

Zhengzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Integration of single-cell and bulk RNA sequencing to identify unique tumor stem cells and construct novel prognostic markers for assessing ESCA prognosis and drug sensitivity.

Integration of single-cell and bulk RNA sequencing to identify unique tumor stem cells and construct novel prognostic markers for assessing ESCA prognosis and drug sensitivity.

Journal: Frontiers in oncology

Published: June 19, 2025

Pilomatrix-like high-grade endometrioid carcinoma of the ovary: report of two cases

Pilomatrix-like high-grade endometrioid carcinoma of the ovary: report of two cases

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology

Published: January 25, 2025

Clinicopathological features of NTRK-rearranged spindle cell neoplasms of the uterus of two cases

Clinicopathological features of NTRK-rearranged spindle cell neoplasms of the uterus of two cases

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology

Published: April 28, 2024

A Novel Cytochrome P450 2E1 Inhibitor Q11 Is Effective on Lung Cancer via Regulation of the Inflammatory Microenvironment.

A Novel Cytochrome P450 2E1 Inhibitor Q11 Is Effective on Lung Cancer via Regulation of the Inflammatory Microenvironment.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 16, 2023

Identification of Cytochrome P450 2E1 as a Novel Target in Glioma and Development of Its Inhibitor as an Anti-Tumor Agent.

Identification of Cytochrome P450 2E1 as a Novel Target in Glioma and Development of Its Inhibitor as an Anti-Tumor Agent.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: February 17, 2023

Cyclin-Dependent Kinase Subunit 2 (CKS2) as a Prognostic Marker for Stages I-III Invasive Non-Mucinous Lung Adenocarcinoma and Its Role in Affecting Drug Sensitivity.

Cyclin-Dependent Kinase Subunit 2 (CKS2) as a Prognostic Marker for Stages I-III Invasive Non-Mucinous Lung Adenocarcinoma and Its Role in Affecting Drug Sensitivity.

Journal: Cells

Published: July 18, 2022

H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation.

H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation.

Journal: Medical science monitor : international medical journal of experimental and clinical research

Published: January 14, 2022

Knockdown of zinc finger protein 267 suppresses diffuse large B-cell lymphoma progression, metastasis, and cancer stem cell properties.

Knockdown of zinc finger protein 267 suppresses diffuse large B-cell lymphoma progression, metastasis, and cancer stem cell properties.

Journal: Bioengineered

Published: January 10, 2022

The POR rs10954732 polymorphism decreases susceptibility to hepatocellular carcinoma and hepsin as a prognostic biomarker correlated with immune infiltration based on proteomics.

The POR rs10954732 polymorphism decreases susceptibility to hepatocellular carcinoma and hepsin as a prognostic biomarker correlated with immune infiltration based on proteomics.

Journal: Journal of translational medicine

Published: November 01, 2021

CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.

CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.

Journal: Bioengineered

Published: September 08, 2021

Use of proteomics to identify mechanisms of hepatocellular carcinoma with the CYP2D6*10 polymorphism and identification of ANGPTL6 as a new diagnostic and prognostic biomarker.

Use of proteomics to identify mechanisms of hepatocellular carcinoma with the CYP2D6*10 polymorphism and identification of ANGPTL6 as a new diagnostic and prognostic biomarker.

Journal: Journal of translational medicine

Published: July 07, 2021

The proteomic characterization of the peritumor microenvironment in human hepatocellular carcinoma.

The proteomic characterization of the peritumor microenvironment in human hepatocellular carcinoma.

Journal: Oncogene

Published: July 05, 2021

Showing 1-12 of 22

Last Updated: 09/26/2026